• NewAmsterdam Pharma (NASDAQ:NAMS) Given Average Rating of "Buy" by Analysts

    Источник: Buzz FX / 26 дек 2024 04:26:13   America/Chicago


    NewAmsterdam Pharma (NASDAQ:NAMS) Given Average Rating of "Buy" by Analysts Written by MarketBeat December 26, 2024 Share Link copied to clipboard. NewAmsterdam Pharma ( NASDAQ:NAMS - Get Free Report ) has received a consensus recommendatio
    Read more...
Опубликовать